Form 8-K - Current report:
SEC Accession No. 0001193125-25-063235
Filing Date
2025-03-26
Accepted
2025-03-26 08:13:28
Documents
20
Period of Report
2025-03-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d931233d8k.htm   iXBRL 8-K 41827
2 EX-1.1 d931233dex11.htm EX-1.1 186500
3 EX-4.1 d931233dex41.htm EX-4.1 81585
4 EX-5.1 d931233dex51.htm EX-5.1 18182
5 EX-10.1 d931233dex101.htm EX-10.1 129550
6 EX-99.1 d931233dex991.htm EX-99.1 8124
10 GRAPHIC g931233dsp0102.jpg GRAPHIC 2685
11 GRAPHIC g931233dsp0103.jpg GRAPHIC 2086
  Complete submission text file 0001193125-25-063235.txt   719414

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA bntc-20250325.xsd EX-101.SCH 2886
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE bntc-20250325_lab.xml EX-101.LAB 17235
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bntc-20250325_pre.xml EX-101.PRE 10836
22 EXTRACTED XBRL INSTANCE DOCUMENT d931233d8k_htm.xml XML 3485
Mailing Address 3940 TRUST WAY HAYWARD CA 94545
Business Address 3940 TRUST WAY HAYWARD CA 94545 (510) 780-0819
Benitec Biopharma Inc. (Filer) CIK: 0001808898 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39267 | Film No.: 25770250
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)